Patents Assigned to 3 D'Art
  • Publication number: 20230149598
    Abstract: Gamma ray and e-beam irradiation provided efficient sterilization of certain self-assembling peptides (including RADA16 in solution) without substantial degradation of the major peptide, while, e.g., another self-assembly peptide, QLEL12 was significantly degraded following irradiation. Irradiation sterilization enhances the rheological property of, for example, RADA16 hydrogel once applied to tissue at a physiological pH. The rheological property increase can result in higher efficacy in a variety of biomedical applications.
    Type: Application
    Filed: November 6, 2022
    Publication date: May 18, 2023
    Applicant: 3-D Matrix, Ltd.
    Inventors: Marika G. Rioult, Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
  • Publication number: 20230149599
    Abstract: Gamma ray and e-beam irradiation provided efficient sterilization of certain self-assembling peptides (including RADA16 in solution) without substantial degradation of the major peptide, while, e.g., another self-assembly peptide, QLEL12 was significantly degraded following irradiation. Irradiation sterilization enhances the rheological property of, for example, RADA16 hydrogel once applied to tissue at a physiological pH. The rheological property increase can result in higher efficacy in a variety of biomedical applications.
    Type: Application
    Filed: December 2, 2022
    Publication date: May 18, 2023
    Applicant: 3-D Matrix, Ltd.
    Inventors: Marika G. Rioult, Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
  • Patent number: 11617778
    Abstract: Provided herein are ionic self-assembling peptides, pharmaceutical compositions comprising the peptides, and methods of using and making the same.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: April 4, 2023
    Assignee: 3-D Matrix, Ltd.
    Inventors: Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
  • Patent number: 11534528
    Abstract: Gamma ray and e-beam irradiation provided efficient sterilization of certain self-assembling peptides (including RADA16 in solution) without substantial degradation of the major peptide, while, e.g., another self-assembly peptide, QLEL12 was significantly degraded following irradiation. Irradiation sterilization enhances the rheological property of, for example, RADA16 hydrogel once applied to tissue at a physiological pH. The rheological property increase can result in higher efficacy in a variety of biomedical applications.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: December 27, 2022
    Assignee: 3-D Matrix, Ltd.
    Inventors: Marika G. Rioult, Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
  • Patent number: 11503991
    Abstract: Embodiments of the present invention may be used to perform measurement of surfaces, such as external and internal surfaces of the human body, in full-field and in 3-D. Embodiments of the present invention may include an electromagnetic radiation source, which may be configured to project electromagnetic radiation onto a surface. The electromagnetic radiation source may be configured to project the electromagnetic radiation in a pattern corresponding to a spatial signal modulation algorithm. The electromagnetic radiation source may also be configured to project the electromagnetic radiation at a frequency suitable for transmission through the media in which the radiation is projected. An image sensor may be configured to capture image data representing the projected pattern.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: November 22, 2022
    Assignee: Virtual 3-D Technologies Corp.
    Inventor: Robert Zeien
  • Patent number: 11497833
    Abstract: Compositions, peptide solutions and macroscopic scaffolds of self-assembling peptides consisting essentially of non-ionic, polar amino acids are provided. Particular peptides include those comprising, or consisting essentially of, serine, threonine, tyrosine, cysteine, glutamine, asparagine, methionine, tryptophan, hydroxy-proline, and combinations thereof. Methods of sterilizing the self-assembling peptides, and scaffolds comprising the peptides are also provided.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: November 15, 2022
    Assignee: 3-D Matrix, Ltd.
    Inventors: Eun Seok Gil, Marika Rioult, Keiji Nagano, Karl Patrick Gilbert, Toshiro Kiyofuji, Yuya Hasegawa
  • Publication number: 20220168462
    Abstract: Systems and methods of blocking a biological vessel 2 are provided. The systems and methods may comprise introducing to the vessel an amphiphilic peptide. The peptide may comprise at least thirteen amino acids that may alternate between a hydrophobic amino acid and a hydrophilic amino acid. The peptide may form a beta- sheet spontaneously in an aqueous solution in the presence of a cation.
    Type: Application
    Filed: November 24, 2021
    Publication date: June 2, 2022
    Applicant: 3-D Matrix, Ltd.
    Inventors: Satoru Kobayashi, Kentaro Takamura
  • Patent number: 11324703
    Abstract: Disclosed herein are surfactant peptide nanostructures wherein the peptides have repeating hydrophobic amino acids in an integer equal to or less than four. The peptide nanostructures are useful for therapeutic applications, including for delivery of drugs and siRNA.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: May 10, 2022
    Assignee: 3-D Matrix, Ltd.
    Inventors: Eun Seok Gil, Elton Aleksi, Noriaki Matsuda
  • Publication number: 20220111126
    Abstract: Methods and materials for mitigating biological tissue adhesion are described herein. One method for mitigating adhesion to a biological tissue includes administering an effective amount of a self-assembling peptide solution to the biological tissue, wherein the self-assembling peptide is between about 7 amino acids and 32 amino acids in length and the self-assembling peptide solution forms a hydrogel under physiological conditions.
    Type: Application
    Filed: November 5, 2021
    Publication date: April 14, 2022
    Applicant: 3-D Matrix, Ltd.
    Inventors: Satoru Kobayashi, Eun Seok Gil, Lisa Spirio
  • Patent number: 11298397
    Abstract: [Problem] To provide a composition for hemostasis that can be applied uniformly to a bleeding site and exerts a high hemostatic effect. [Solution] Provided is a composition to be applied to the subject as a spray, wherein the composition is characterized in that the spray is for hemostasis, and the composition includes a self-assembling peptide, the self-assembling peptide gelling due to self-assembly when the composition is applied to the bleeding site of the subject, and the self-assembling peptide being included in the composition in a concentration having an improved hemostatic capacity in comparison to direct application.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: April 12, 2022
    Assignee: 3-D Matrix, Ltd.
    Inventors: Keiji Nagano, Satoru Kobayashi
  • Patent number: 11260072
    Abstract: Provided are methods and compositions useful in the diagnosis, treatment, and monitoring of osteosarcoma. Antisense to certain microRNA (miRNA) found to be associated with cancer stem cells (CSCs) or tumor-initiating cells (TICs) of osteosarcoma are useful to suppress tumor growth and metastasis, and prolong survival. Antisense oligonucleotides to miR-133a are synergistic in combination with standard chemotherapy such as cisplatin in the treatment of osteosarcoma.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: March 1, 2022
    Assignee: 3-D Matrix, Ltd.
    Inventors: Takahiro Ochiya, Tomohiro Fujiwara
  • Patent number: 11153696
    Abstract: Systems and methods are disclosed for making three-dimensional models of the inside of an ear canal using a projected pattern. A system comprises a probe adapted to be inserted into the ear canal. The probe comprises a narrow portion adapted to fit inside the ear canal and a wide portion adapted to be wider than the ear canal, which may be formed by a tapered stop. An illumination subsystem projects a pattern of light from the distal end of the probe onto a surface of the ear canal, the pattern being modulated by the three-dimensional surface of the ear canal. An imaging subsystem captures a series of individual images of the pattern of light projected onto the surface of the ear canal. A computer subsystem calculates digital three-dimensional representations from the individual images and stitches them together to generate a digital three-dimensional model of the ear canal.
    Type: Grant
    Filed: February 12, 2018
    Date of Patent: October 19, 2021
    Assignee: VIRTUAL 3-D TECHNOLOGIES CORP.
    Inventor: Robert Zeien
  • Publication number: 20210299326
    Abstract: Gamma ray and e-beam irradiation provided efficient sterilization of certain self-assembling peptides (including RADA16 in solution) without substantial degradation of the major peptide, while, e.g., another self-assembly peptide, QLEL12 was significantly degraded following irradiation. Irradiation sterilization enhances the rheological property of, for example, RADA16 hydrogel once applied to tissue at a physiological pH. The rheological property increase can result in higher efficacy in a variety of biomedical applications.
    Type: Application
    Filed: March 30, 2021
    Publication date: September 30, 2021
    Applicant: 3-D Matrix, Ltd.
    Inventors: Marika G. Rioult, Eun Seok Gil, Elton Aleksi, Naoki Yamamoto
  • Patent number: 11090398
    Abstract: Methods and devices for sterilizing viscous peptide compositions which have shear thinning rheological properties at high concentrations.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: August 17, 2021
    Assignee: 3-D Matrix, Ltd.
    Inventors: Eun Seok Gil, Karl Patrick Gilbert
  • Publication number: 20210215713
    Abstract: The present invention to a method, a kit, etc., for predicting the response BNCT using a BSH-related medicine-containing boron preparation and a BPA-containing boron preparation, the method and kit being characterized by examining the expression of CD44, a translation-related factor and/or LAT1 in cancer cells of a sample. When the expression of the CD44 or translation-related factor in the cancer cells of the sample is high, it can be predicted that the BNCT using the BSSH-related medicine-containing boron preparation is likely to be responsive. When the expression of the LAT1 in the cancer cells of the sample is high, it can be predicted that the BNCT using the BPA-containing boron preparation is likely to be responsive.
    Type: Application
    Filed: February 8, 2019
    Publication date: July 15, 2021
    Applicant: 3-D MATRIX, LTD.
    Inventors: Hideki MATSUI, Atsushi FUJIMURA
  • Patent number: 10961274
    Abstract: Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion are provided herein. Compositions, peptide solutions and macroscopic scaffolds of self-assembling peptides consisting essentially of non-ionic, polar amino acids are provided to prevent adhesion or to provide anti-adhesion properties. Particular peptides include those consisting essentially of, serine, threonine, tyrosine, cysteine, glutamine, asparagine, methionine, tryptophan, hydroxy-proline, and combinations thereof. Methods and kits are also provided.
    Type: Grant
    Filed: December 15, 2016
    Date of Patent: March 30, 2021
    Assignee: 3-D Matrix, Ltd.
    Inventors: Eun Seok Gil, Marc Rioult, Keiji Nagano, Karl Patrick Gilbert, Toshiro Kiyofuji, Yuya Hasegawa
  • Patent number: 10876689
    Abstract: A lighting tube for uniform illumination is disclosed. The lighting tube includes a conduit having an inner layer, outer layer, and a middle layer between the inner and outer layers. The middle layer has at least two of a phosphor film, a diffusion film, and a UV-blocking film. The lighting tube also includes a light emitting chain located inside of the conduit. The light emitting chain includes control wires and a plurality of light emitting units spaced along the control wires. Each unit has a plurality of faces interconnected to form a polygon when viewed along a central axis, with each face being on a different side of the polygon. Each face has an LED coupled to the control wires. The LED emits light with a wavelength that causes the phosphor film to luminesce. The illumination of the middle layer by the chain is substantially uniform in all radial directions.
    Type: Grant
    Filed: December 12, 2019
    Date of Patent: December 29, 2020
    Assignee: Retinal 3-D, L.L.C.
    Inventor: Roger C. Bowser
  • Patent number: 10835637
    Abstract: The present invention relates to a triblock copolymer having a polyethylene glycol-poly(D,L-lactide)-polyethylene glycol skeleton.
    Type: Grant
    Filed: August 23, 2016
    Date of Patent: November 17, 2020
    Assignees: 3-D Matrix, Ltd. (Tokyo, Japan), Tokyo University of Science Foundation
    Inventors: Hidenori Otsuka, Daisuke Matsukuma, Noriaki Matsuda
  • Patent number: 10814038
    Abstract: Combination compositions comprising self-assembling peptides and payload agents, and methods of making and using such compositions, are described.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: October 27, 2020
    Assignees: 3-D Matrix, Ltd., Vicus Therapeutics, LLC
    Inventors: John Maki, Eun Seok Gil, Lisa Spirio
  • Patent number: 10793307
    Abstract: The enclosed disclosure describes, among other things, a method including the steps of a first deaerating step in which a mixture comprising peptides is deaerated by lowering the pressure, filtering the mixture through a sterilizing filter; and a second deaerating step, in which the filtrate is deaerated by vibration and lowering the pressure.
    Type: Grant
    Filed: July 3, 2013
    Date of Patent: October 6, 2020
    Assignee: 3-D Matrix, Ltd.
    Inventors: Masahiro Nohara, Yuya Hasegawa